DANZITEN
NDC 24338-155, nilotinib, tablet, from Azurity Pharmaceuticals, Inc..
- Product NDC
- 24338-155
- Status
- Listed
- Labeler
- Azurity Pharmaceuticals, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA219293
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/24338-155 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NILOTINIB95 mg/1
Pharmacologic classes
Bcr-Abl Tyrosine Kinase Inhibitors [MoA]; Cytochrome P450 2B6 Inducers [MoA]; Cytochrome P450 2C8 Inducers [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]; Kinase Inhibitor [EPC]; P-Glycoprotein Inhibitors [MoA]; UGT1A1 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 24338-155-01 | 24338015501 | 4 CARTON in 1 CARTON (24338-155-01) / 2 BLISTER PACK in 1 CARTON (24338-155-02) / 14 TABLET in 1 BLISTER PACK (24338-155-03) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/d288d165-3505-49bb-9b2e-124490d65f49
Use it
Look up 24338-155 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/24338-155 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 24338-155. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.